Sales and Marketing

Showing 15 posts of 11527 posts found.

BMS signs cancer deal

May 28, 2014 Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

Don’t trust ‘inaccurate’ and ‘harmful’ Dr Wikipedia

May 28, 2014 Medical Communications, Sales and Marketing American Osteopathic Association, online, wikimedia, wikipedia

Doctors are warning that patients and members of their own profession are increasingly turning to Wikipedia for medical information, but …

New biomedical engineering centre for Imperial

May 28, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, imperial college london, johnson, medcity, uren

Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …

Clinigen chief executive joins Ergomed board

May 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, ergomed, george

UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

  George has over 20 …

Pfizer admits AstraZeneca defeat

May 27, 2014 Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, Pfizer, Read, buyout, merger

Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …

We can’t go on like this: patients must come first

May 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, bowel, denegri, flannagan, patients

When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …

Wave of appointments for UK firm

May 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing hatch, wave

Amersham-based UK medical education company Wave has appointed three new members of staff. Charlotte Wilkinson joins as programme manager and …

Biogen gets CHMP thumbs up

May 27, 2014 Sales and Marketing Biogen, CHMP, Gazyvaro (obinutuzumab), Nuwiq, Octapharma, Orphan, Roche, chronic lymphocytic leukaemia, plegridy

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014 Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

Janssen abandons Simponi application

May 23, 2014 Sales and Marketing Europe, Janssen, RA, Simponi, rheumatoid arthritis

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

Merck Serono rapped over hospitality

May 23, 2014 Medical Communications, Sales and Marketing ABPI, Merck KGaA, Merck Serono, PMCPA

The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …

PAN appoints two and promotes three

May 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pan, doshi, fleming, gibbs, regan, valentine

Creative agency PAN has reinforced its account handling and planning teams with two new arrivals and three promotions. Aisha Regan …

Authorities visit Roche China offices

May 23, 2014 Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic

A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …

Novartis pays $200m for eye technology

May 22, 2014 Sales and Marketing Novartis, eye technology, fovista, ophthotech, wet and

Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …

PM Society announces new co-chairs

May 22, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PRIME, farrow, jones, o'brien, pm society

The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
The Gateway to Local Adoption Series

Latest content